Taxim O 200mg

Taxim O 200 mg should not be used in patients with known allergies to cephalosporin or penicillin antibiotics. If an allergic reaction occurs, the drug should be discontinued, and if required, the patient should be treated with appropriate agents, e.g. Antihistamines, pressor amines, or corticosteroids. Cefixime should be prescribed cautiously in individuals with a history of gastrointestinal disease. Once daily dose must be used for urinary tract infections since twice daily dosing was ineffective in research studies. Caution should be exercised when prescribing to pregnant ladies. The medicine should not be given to pregnant women unless considered essential by the health care specialist.

Cefixime's side effects are nausea, vomiting, diarrhoea, dizziness, joint pain, vaginal itching or discharge. These effects are not serious and should go away after some time. The details provided here are limited and non-exhaustive. You may experience some side effects which have no reference over here. If you feel the serious effects, do not hesitate to seek emergency medical assistance. Do not get alarmed by the list. You may /may not experience all of them. Tell your doctor immediately about the above situation.

Taxim O 200 mg is a prescription drug and should be taken in dosage as prescribed. Taxim O 200 mg is available for oral administration only. It should be used with enough water. The tablet may be taken before or after consuming food. The usual course of treatment is seven days. This may be continued for up to 14 days if required.

For adults, the recommended dose is 200 to 400 mg daily, according to the severity of the infection, taken as a single dose. Elderly patients may be given the same dose as suggested for adults. Kidney function will be assessed, and dosage will be adjusted in patients with kidney impairment. Cefixime tablets should be used with caution in adult patients with renal impairment. Adolescents greater than twelve years of age may be given the same dose as recommended for adults. The safety and effectiveness of the medicine have not been established in children under six months of age.